TickerFactsScreenerDevelopers

Galera Therapeutics, Inc. (GRTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$24.25M2019: -$50.69M2020: -$70.55M2021: -$73.37M2022: -$51.23M2023: -$49.26M2024: -$20.16M2025: -$2.54M-$2.54M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$2.54M+87.4%
2024-$20.16M+59.1%
2023-$49.26M+3.8%
2022-$51.23M+30.2%
2021-$73.37M-4.0%
2020-$70.55M-39.2%
2019-$50.69M-109.0%
2018-$24.25M—